arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ORASURE TECHNOLOGIES INC

OSUR
$4.01 ▲ +0.02 (+0.50%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORASURE TECHNOLOGIES INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $276.7M
Dividend Yield
Revenue Growth -1.9%
Op. Margin 17.8%
ROIC 1.4%
FCF / Share $-0.18
Trailing P/E 44.6x
Price / Book 0.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.64M
↓ -1.9%
Net Income Profit after all expenses
$-22.38M
↓ -39.5%
Operating Margin Operating profit as % of sales
17.8%
↑ +121.3% 4th
FCF / Share Free cash flow per share
$-0.18
↑ +15.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
28
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters